Atomoxetine improves teacher rated symptoms in children with ADHD more than placeboA randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.

  • Barton, Joanne MBChB PhD MRCPsych (commentator)
  • Weiss, M
  • Tannock, R
  • Kratochvil, C
  • et al,

  • Consultant Child and Adolescent Psychiatrist, Stoke-On-Trent, UK

Weiss M, Tannock R, Kratochvil C, et al. A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 2005; 44: 647–55.WeissMTannockRKratochvilCet alA randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.J Am Acad Child Adolesc Psychiatry200544647-55Q Is once-daily atomoxetine more effective than placebo at reducing attention deficit hyperactivity disorder (ADHD) symptoms displayed at school?

For correspondence: Dr A J Allen, Lilly Corporate Center, Indianapolis, IN 46285, USA; [email protected]

Sources of funding: Eli Lilly and Company.

Evidence-Based Mental Health 9(1):p 7, February 2006.
Copyright © 2006 by BMJ Publishing Group Ltd, Royal College of Psychiatrists, & British Psychological Society